Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $9.649B (99.0% shares, 1.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ONC | BeiGene, Ltd. | 10,568,897 | $2.373B | 24.6% | $136.93 | — | SPONSORED ADR | 07725L102 |
| INCY | Incyte Corporation | 30,739,020 | $2.032B | 21.1% | $72.80 | -12.4% | COM | 45337C102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,877,916 | $659M | 6.8% | $18.93 | -11.9% | COM | 004225108 |
| SMMT | Summit Therapeutics Inc. | 24,424,865 | $535M | 5.5% | $5.82 | +140.2% | COM | 86627T108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,974,590 | $419M | 4.3% | $119.77 | +113.6% | COM | 558868105 |
| RVMD | Revolution Medicines, Inc. | 7,569,090 | $343M | 3.6% | $26.62 | +63.6% | COM | 76155X100 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 6,398,366 | $335M | 3.5% | $23.49 | +104.0% | COM | 76243J105 |
| INSM | Insmed Incorporated | 4,415,918 | $322M | 3.3% | $43.95 | +67.9% | COM PAR $.01 | 457669307 |
| KYMR | Kymera Therapeutics, Inc. | 5,995,929 | $284M | 2.9% | $28.14 | +56.9% | COM | 501575104 |
| BCYC | Bicycle Therapeutics plc | 9,399,960 | $213M | 2.2% | $21.86 | — | SPONSORED ADS | 088786108 |
| EWTX | Edgewise Therapeutics, Inc. | 5,840,059 | $156M | 1.6% | $13.32 | +49.4% | COM | 28036F105 |
| REPL | Replimune Group, Inc. | 11,045,336 | $121M | 1.3% | $14.45 | -29.7% | COM | 76029N106 |
| ALKS | Alkermes plc | 4,181,751 | $117M | 1.2% | $24.53 | +8.7% | SHS | G01767105 |
| DNLI | Denali Therapeutics Inc. | 3,731,695 | $109M | 1.1% | $23.78 | +4.2% | COM | 24823R105 |
| — | Insmed Incorporated | 42,850,000 | $98.33M | 1.0% | $2.11 | — | Note 0.75% 6/1/2028 | 457669AB5 |
| RARE | Ultragenyx Pharmaceutical Inc. | 1,576,114 | $87.55M | 0.9% | $64.34 | -20.8% | COM | 90400D108 |
| NRIX | Nurix Therapeutics, Inc. | 3,882,125 | $87.23M | 0.9% | $22.27 | +1.7% | COM | 67080M103 |
| TRDA | Entrada Therapeutics, Inc. | 4,865,819 | $77.76M | 0.8% | $16.96 | — | COM | 29384C108 |
| IMTX | Immatics N.V. | 6,443,398 | $73.52M | 0.8% | $10.87 | +8.9% | SHS | N44445109 |
| ABCL | AbCellera Biologics Inc. | 27,525,640 | $71.57M | 0.7% | $21.02 | -86.8% | COM | 00288U106 |
| KNSA | Kiniksa Pharmaceuticals International, plc | 2,818,323 | $70.43M | 0.7% | $18.73 | +30.0% | ORD SHS CL A | G52694109 |
| — | IGM Biosciences, Inc. | 4,092,310 | $67.69M | 0.7% | $15.73 | — | COM | 449585108 |
| ARGX | argenx SE | 111,904 | $60.66M | 0.6% | $79.01 | — | SPONSORED ADR | 04016X101 |
| STOK | Stoke Therapeutics, Inc. | 4,368,443 | $53.69M | 0.6% | $9.12 | +55.3% | COM | 86150R107 |
| IMCR | Immunocore Holdings plc | 1,515,318 | $47.17M | 0.5% | $42.57 | — | ADS | 45258D105 |
| KOD | Kodiak Sciences Inc. | 17,310,490 | $45.18M | 0.5% | $30.30 | -91.2% | COM | 50015M109 |
| SERA | Sera Prognostics, Inc. | 5,434,399 | $42.39M | 0.4% | $3.07 | +136.4% | CLASS A COM | 81749D107 |
| CRSP | CRISPR Therapeutics AG | 843,075 | $39.61M | 0.4% | $51.58 | -1.6% | NAMEN AKT | H17182108 |
| XENE | Xenon Pharmaceuticals Inc. | 993,679 | $39.12M | 0.4% | $18.51 | +117.9% | COM | 98420N105 |
| IMVT | Immunovant, Inc. | 1,225,410 | $34.94M | 0.4% | $27.07 | +9.0% | COM | 45258J102 |
| CERS | Cerus Corporation | 19,477,339 | $33.89M | 0.4% | $4.19 | -49.8% | COM | 157085101 |
| IDYA | IDEAYA Biosciences, Inc. | 1,062,123 | $33.65M | 0.3% | $14.62 | +159.3% | COM | 45166A102 |
| ROIV | Roivant Sciences Ltd. | 2,798,716 | $32.3M | 0.3% | $8.98 | +26.7% | SHS | G76279101 |
| — | Akero Therapeutics, Inc. | 1,097,082 | $31.48M | 0.3% | $32.79 | — | COM | 00973Y108 |
| KRYS | Krystal Biotech, Inc. | 169,934 | $30.93M | 0.3% | $34.45 | +459.7% | COM | 501147102 |
| CELC | Celcuity Inc. | 1,874,978 | $27.96M | 0.3% | $14.35 | +14.9% | COM | 15102K100 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,916,095 | $26.06M | 0.3% | $6.49 | -22.3% | COM | 61225M102 |
| DYN | Dyne Therapeutics, Inc. | 672,096 | $24.14M | 0.3% | $26.33 | +51.2% | COM | 26818M108 |
| BMEA | Biomea Fusion, Inc. | 2,108,949 | $21.3M | 0.2% | $8.56 | -24.1% | COM | 09077A106 |
| BCAX | Bicara Therapeutics Inc. | 833,333 | $21.22M | 0.2% | $25.50 | 0.0% | COM | 055477103 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $20.96M | 0.2% | $28.24 | -83.6% | COM | 74065P101 |
| CNTA | Centessa Pharmaceuticals plc | 1,227,178 | $19.62M | 0.2% | $12.88 | — | SPONSORED ADS | 152309100 |
| NGNE | Neurogene Inc. | 456,015 | $19.13M | 0.2% | $14.32 | +170.8% | COM | 64135M105 |
| PRAX | Praxis Precision Medicines, Inc. | 323,105 | $18.59M | 0.2% | $50.29 | +7.4% | COM | 74006W207 |
| ALMS | Alumis Inc. | 1,562,500 | $16.69M | 0.2% | $13.30 | -8.8% | COM | 022307102 |
| — | Merus N.V. | 300,000 | $14.99M | 0.2% | $59.17 | — | COM | N5749R100 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $13.87M | 0.1% | $6.08 | -0.8% | COM | 89854M101 |
| NMRA | Neumora Therapeutics, Inc. | 1,034,600 | $13.67M | 0.1% | $13.91 | -16.2% | COM | 640979100 |
| XNCR | Xencor, Inc. | 670,431 | $13.48M | 0.1% | $21.77 | -13.8% | COM | 98401F105 |
| — | 2seventy bio, Inc. | 2,497,526 | $11.79M | 0.1% | $18.72 | — | COMMON STOCK | 901384107 |
| FATE | Fate Therapeutics, Inc. | 2,997,772 | $10.49M | 0.1% | $5.48 | -29.0% | COM | 31189P102 |
| ARVN | Arvinas, Inc. | 405,576 | $9.989M | 0.1% | $26.11 | 0.0% | COM | 04335A105 |
| SANA | Sana Biotechnology, Inc. | 2,380,949 | $9.905M | 0.1% | $4.55 | +15.3% | COM | 799566104 |
| DSGN | Design Therapeutics, Inc. | 1,743,725 | $9.381M | 0.1% | $12.06 | -61.0% | COM | 25056L103 |
| IONS | Ionis Pharmaceuticals, Inc. | 223,470 | $8.952M | 0.1% | $46.53 | 0.0% | COM | 462222100 |
| OPTEY | Opthea Limited | 2,173,622 | $8.847M | 0.1% | $11.12 | — | SPONSORED ADS | 68386J208 |
| CLDX | Celldex Therapeutics, Inc. | 247,644 | $8.417M | 0.1% | $29.41 | +29.5% | COM | 15117B202 |
| RLAY | Relay Therapeutics, Inc. | 1,160,117 | $8.214M | 0.1% | $13.78 | -45.8% | COM | 75943R102 |
| — | Verve Therapeutics, Inc. | 1,691,530 | $8.187M | 0.1% | $52.72 | — | COM | 92539P101 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $8.05M | 0.1% | $1.91 | +14.6% | COM SHS | 877619106 |
| MIRM | Mirum Pharmaceuticals, Inc. | 190,476 | $7.429M | 0.1% | $27.38 | +45.7% | COM | 604749101 |
| CTNM | Contineum Therapeutics, Inc. | 312,500 | $5.981M | 0.1% | $16.10 | +19.1% | CL A | 21217B100 |
| TNGX | Tango Therapeutics, Inc. | 750,000 | $5.775M | 0.1% | $11.99 | -20.4% | COM | 87583X109 |
| SKYE | Skye Bioscience, Inc. | 1,434,634 | $5.609M | 0.1% | $7.78 | -27.9% | COM | 83086J200 |
| PCVX | Vaxcyte, Inc. | 48,885 | $5.586M | 0.1% | $39.24 | +129.7% | COM | 92243G108 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 103,927 | $5.311M | 0.1% | $46.18 | +11.7% | COM | 22663K107 |
| — | DBV Technologies S.A. | 7,307,131 | $5.115M | 0.1% | $0.80 | — | SPONSORED ADR | 23306J200 |
| KALA | KALA BIO, Inc. | 891,335 | $5.081M | 0.1% | $8.21 | -23.2% | COM | 483119202 |
| — | Generation Bio Co. | 1,944,945 | $4.804M | 0.0% | $2.93 | — | COM | 37148K100 |
| ALEC | Alector, Inc. | 927,264 | $4.321M | 0.0% | $5.15 | +4.2% | COM | 014442107 |
| PRME | Prime Medicine, Inc. | 1,028,466 | $3.98M | 0.0% | $18.06 | -74.4% | COM | 74168J101 |
| SGMT | Sagimet Biosciences Inc. | 1,381,898 | $3.828M | 0.0% | $9.53 | -67.7% | COM SER A | 786700104 |
| GPCR | Structure Therapeutics Inc. | 85,500 | $3.753M | 0.0% | $43.89 | — | SPONSORED ADS | 86366E106 |
| ARCT | Arcturus Therapeutics Holdings Inc. | 151,329 | $3.512M | 0.0% | $30.32 | -29.5% | COM | 03969T109 |
| HOOK | HOOKIPA Pharma Inc. | 812,814 | $3.495M | 0.0% | $7.93 | -33.4% | COM | 43906K209 |
| CYPH | Leap Therapeutics, Inc. | 1,172,175 | $3.012M | 0.0% | $5.02 | -51.1% | COM | 52187K200 |
| ELVN | Enliven Therapeutics, Inc. | 114,833 | $2.933M | 0.0% | $15.34 | +50.9% | COM | 29337E102 |
| CMPX | Compass Therapeutics, Inc. | 1,557,630 | $2.866M | 0.0% | $3.99 | -68.8% | COM | 20454B104 |
| WVE | Wave Life Sciences Ltd. | 344,063 | $2.821M | 0.0% | $5.98 | 0.0% | SHS | Y95308105 |
| — | Mersana Therapeutics, Inc. | 1,086,115 | $2.053M | 0.0% | $4.11 | — | COM | 59045L106 |
| NAMS | NewAmsterdam Pharma Company N.V. | 96,711 | $1.605M | 0.0% | $20.30 | -14.8% | ORDINARY SHARES | N62509109 |
| IPSC | Century Therapeutics, Inc. | 797,460 | $1.364M | 0.0% | $9.79 | -80.0% | COM | 15673T100 |
| VTVT | vTv Therapeutics, Inc. | 97,314 | $1.32M | 0.0% | $12.72 | +30.2% | CL A | 918385204 |
| — | Aerovate Therapeutics, Inc. | 628,939 | $1.314M | 0.0% | $21.15 | — | COM | 008064107 |
| PFE | Pfizer Inc. | 35,000 | $1.013M | 0.0% | $26.40 | +1.1% | COM | 717081103 |
| TARA | Protara Therapeutics, Inc. | 536,832 | $982K | 0.0% | $13.35 | -84.6% | COM STK | 74365U107 |
| ALGS | Aligos Therapeutics, Inc. | 83,055 | $719K | 0.0% | $12.44 | 0.0% | COM | 01626L204 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 75,778 | $576K | 0.0% | $6.35 | +19.7% | COM | 09058V103 |
| PMVP | PMV Pharmaceuticals, Inc. | 322,024 | $480K | 0.0% | $14.45 | -89.3% | COM | 69353Y103 |
| FHTX | Foghorn Therapeutics Inc. | 45,027 | $419K | 0.0% | $14.37 | -49.6% | COM | 344174107 |
| ACRV | Acrivon Therapeutics, Inc. | 52,885 | $370K | 0.0% | $4.64 | +69.8% | COMMON STOCK | 004890109 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $249K | 0.0% | $12.95 | +62.2% | COM | 90240B106 |
| SRZNW | Surrozen, Inc. | 833,333 | $8,583 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |